|
Dec 31
|
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device
|
|
Dec 31
|
Inogen Expands U.S. Market with FDA Clearance
|
|
Dec 31
|
FDA grants clearance for Inogen’s SIMEOX 200 airway clearance device
|
|
Dec 30
|
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
|
|
Dec 24
|
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
|
|
Dec 21
|
Inogen, Inc. (NASDAQ:INGN) is a favorite amongst institutional investors who own 78%
|